Pharmabiz12 分钟
Tonix Pharma enters research agreement with KEMRI to design, plan and seek regulatory ...
Chatham, New Jersey Wednesday, November 6, 2024, 18:00 Hrs [IST] ...
centerforbiosimilars15 分钟
Celltrion Sets Sights on 2030 With Expanded Biosimilar Portfolio, Market Reach
Celltrion plans to commercialize 22 biosimilars by 2030, expanding its global presence with robust sales growth driven by core biosimilars and new launches like subcutaneous infliximab.